IL15 and neoplasm: ILC1s are defined by the master transcription factor T-bet and are activated by the presence of IL-12, IL-15, and IL-18 to mount an anti-viral and anti-tumor response by producing effector cytokines IFNγ and TNF-α [3, 4].